Sectoral Asset Management Inc. grew its position in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) by 235.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 201,000 shares of the company’s stock after purchasing an additional 141,000 shares during the period. Sectoral […]